Sea Moss (Irish Moss) for Thyroid Function
Verdict: Sea moss does not help thyroid; it can harm
There is no credible evidence that sea moss (Irish moss) supports thyroid function, and its highly variable, often unlabeled iodine load can disrupt the thyroid in either direction. Leading thyroid authorities advise against seaweed and kelp supplements for this purpose.
D 🔴 D Counter-Evidence Safety Review
Why this grade7-layer evidence engine
This earns the lowest grade, counter-evidence with a safety review, because the data point to potential harm rather than mere ineffectiveness. No human trial has ever tested Chondrus crispus itself for thyroid function. Instead, a high-quality systematic review (PMID 33981614) and an analytical survey (PMID 15588380) show that seaweed iodine content is extreme and unpredictable, spanning more than a 500-fold range across products and up to ten-fold within a single species, so a capsule's actual dose cannot be known without batch testing.
Direct human data on seaweed iodine show real thyroid effects. A 2026 cessation study (PMID 41543576, n=49) found habitual consumers had excess iodine and elevated TSH that fell significantly after six weeks off seaweed, with the largest improvements in the heaviest users. A cross-sectional cohort (PMID 33202773, n=44) found uniformly excessive iodine and higher TSH, and even a low-dose seaweed RCT (PMID 25006699, n=42) raised TSH within two weeks. Case reports (PMIDs 25355748, 31517826, 16808731) document seaweed-triggered hyperthyroidism and biphasic dysfunction even in previously healthy people.
Regulators and clinics agree. The EFSA warns that seaweed pushes iodine and heavy-metal intake above safe limits, the NHS says not to combine kelp supplements with levothyroxine, and NIH's LactMed notes that no medicinal value has been proven. Cleveland Clinic, Harvard, and the American Thyroid Association explicitly advise against seaweed or kelp supplements for thyroid use and state there is no known thyroid benefit. The popular 'natural thyroid support' claim is unsupported, while the documented risk, including interference with thyroid medication, is real.
⚖️
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditableRaw score 0.39
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
D · Safety Review
Confidence
83%
Highly consistent evidence
Evidence level
E3
Single high-quality meta-analysis
▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.392
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 無高階證據可裁決
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
PubMed studies (8)L2 · primary research & systematic reviews
Iodine, Seaweed, and the Thyroid (Aakre I, Tveito Evensen L et al.; Eur Thyroid J)
Finding: Seaweed is the most iodine-dense food source on Earth with extreme inter- and intra-species variability; brown seaweeds (kelp, kombu, wakame) regularly exceed tolerable upper limits even in single servings, while red algae including Chondrus crispus (Irish moss / sea moss) are 1-2 orders of magnitude lower but still highly variable. Review documents repeated case reports of seaweed-induced hyperthyroidism (Jod-Basedow) and hypothyroidism (failure to escape Wolff-Chaikoff). Authors recommend against unregulated seaweed supplements; salt iodization remains the preferred public-health route to iodine sufficiency.
View on PubMed Impact of habitual seaweed consumption on iodine nutrition and thyroid function: a non-randomized pre-post clinical study
Finding: Habitual seaweed consumers had excessive iodine status (median UIC 270 mcg/L) and elevated TSH. Cessation of seaweed for 6 weeks significantly reduced median UIC to 87 mcg/L (p<0.001) and significantly decreased serum TSH, with the largest TSH improvements in highest-iodine consumers. Direct evidence that habitual seaweed intake suppresses thyroid function in a dose-dependent manner reversible on withdrawal.
View on PubMed Iodine Status and Thyroid Function in a Group of Seaweed Consumers in Norway (Aakre I et al.)
Finding: All 44 seaweed consumers had excessive iodine status (UIC >300 mcg/L per WHO classification); median UIC 1200 mcg/L. TSH levels remained within reference range but were 'higher than in other comparable population groups,' indicating subclinical thyroid stress. Authors warn that absence of iodine labeling on seaweed products leaves consumers unaware of excess exposure and recommend consumer warnings.
View on PubMed Variability of iodine content in common commercially available edible seaweeds (Teas J et al.)
Finding: Iodine content of commercial seaweeds spans >500-fold range; 'some Asian seaweed dishes may exceed the tolerable upper iodine intake level of 1,100 mcg/day.' Preharvest conditions (season, location, plant age) and post-harvest processing (sun-bleaching, granulation) substantially affect content. Establishes that label or product class is insufficient to predict iodine dose — direct laboratory testing of each batch is required.
View on PubMed Thyroid dysfunction following a kelp-containing marketed diet (Di Matola T et al.; BMJ Case Rep)
Finding: Previously euthyroid 45-year-old woman developed Jod-Basedow hyperthyroidism within weeks of starting kelp-containing diet, then progressed to overt iodine-induced hypothyroidism ~2 months after diet cessation (failure to escape Wolff-Chaikoff). Required 3 months of levothyroxine to normalize. Concludes 'herbal medicine or diets for weight loss containing kelp should be avoided also in participants with no evidence of thyroid disease.'
View on PubMed Transient Hyperthyroidism following the ingestion of complementary medications containing kelp seaweed: A case-report (Picciotto D et al.)
Finding: 70-year-old woman with no prior thyroid disease developed transient hyperthyroidism (tachycardia, insomnia, anxiety, 6 kg weight loss in 3 months) after ingesting kelp tablets. Normal thyroid function regained after 3 months of antithyroid therapy plus withdrawal. Doppler ultrasound suggested Jod-Basedow phenomenon. Authors recommend that 'adults who consume complementary medication based on kelp seaweed should be informed of the risk of developing thyroid dysfunction also in the absence of any pre-existing thyroid disease.'
View on PubMed Iodine-induced thyrotoxicosis after ingestion of kelp-containing tea (Mussig K et al.; J Gen Intern Med)
Finding: 39-year-old woman with multinodular goiter developed overt hyperthyroidism after 4 weeks of kelp tea. Recovery on antithyroid medication plus cessation. Authors conclude 'physicians should advise patients with underlying thyroid disease to avoid all complementary or alternative medications containing iodine,' establishing the heightened risk of Jod-Basedow in pre-existing nodular goiter.
View on PubMed Low-level seaweed supplementation improves iodine status in iodine-insufficient women (Combet E et al.; Br J Nutr)
Finding: Two-week low-dose A. nodosum supplementation in iodine-insufficient women raised UIC from 78 to 140 mcg/L (p<0.001) — correcting mild deficiency — but simultaneously raised TSH from 1.5 to 2.1 mIU/L (p<0.001), with 2/42 participants exceeding normal TSH range, indicating early subclinical hypothyroidism even at moderate doses. Bioavailability 33% vs 59% for KI. Demonstrates that even 'low-level' seaweed dosing in deficient populations carries detectable thyroid risk.
View on PubMed Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …
L4a US FDA
Cautious
ANTICAKING AGENT OR FREE-FLOW AGENT, DRYING AGENT, EMULSIFIER OR EMULSIFIER SALT, FLAVOR ENHANCER, FLAVORING AGENT OR ADJUVANT, FORMULATION AID, HUMECTANT, PROCESSING AID, STABILIZER OR THICKENER, TEXTURIZER source↗
L4b EU EFSA
Against
the consumption of seaweed can lead to a significantly increased exposure to metals, for which the intake from a diet without seaweed already exceeds the health-based guidance values. Furthermore, it can lead to high iodine intakes, which can lead to exceeding the established upper limit value. source↗
L4d TW TFDA / 衛福部
Neutral
110 年 11 月 12 日衛授食字第 1101902563 號公告修正並自 112 年 1 月 1 日生效 §12012 鹿角菜膠 Carrageenan（食品添加物規格檢驗方法）；食用藻類及其製品應符合衛福部公告之食用藻類衛生標準，依紅藻、褐藻、綠藻及藍藻分類管制重金屬等污染物限量。 source↗
L4e WHO
Cautious
the use of carrageenan in infant formula or formula for special medical purposes at concentrations up to 1000 mg/L is not of concern source↗
L5a NIH Office of Dietary Supplements
Cautious
Sea moss or Irish moss (Chondrus crispus) is a type of red seaweed that is used as food and medicine, although no medicinal value has been proven... Sea moss should be avoided during breastfeeding unless the levels of iodine and heavy metals have been shown to be low enough to be safe. source↗
L5c Cleveland Clinic
Cautious
If you already have hyperthyroidism or hypothyroidism, don't take sea moss unless specifically advised by your healthcare provider. source↗
L5d Harvard Health
Cautious
Excessive intakes can sometimes lower the production of thyroid hormones and lead to a condition called hypothyroidism. ... Studies have found that regular intake of seaweed (several servings a week) can increase blood levels of thyroid stimulating hormone, which is a risk factor for hypothyroidism. ... Certain groups may be more sensitive to excessive iodine and should limit their intake of se… source↗
L5e Specialty Society (condition-mapped)
Against
The American Thyroid Association advises against the ingestion of iodine and kelp supplements containing in excess of 500 mcg iodine daily for children and adults and during pregnancy and lactation. Ingestion of greater than 1,100 mcg of iodine per day (Tolerable Upper Limit for iodine) is not recommended and may cause thyroid dysfunction. There is no known thyroid benefit of routine daily iodi… source↗